Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Erba Mannheim, also referred to as Erba Group, is a global in vitro diagnostics company focused on delivering affordable diagnostic instruments, reagents, and support services, particularly for developing markets. Founded in India in 1979 as Transasia Bio-Medicals and expanded internationally through Erba Mannheim and affiliated subsidiaries, the group serves hospitals and laboratories in more than 100 countries. Its portfolio spans clinical chemistry, hematology, urinalysis, diabetes management, immunology, molecular diagnostics, microbiology, coagulation, and critical care. The company operates through a network of regional subsidiaries and manufacturing entities in Europe, India, the United States, and other markets. Erba is primarily a commercial diagnostics business rather than a therapeutics developer, with revenue generated from diagnostic analyzers, consumables, and laboratory testing solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Erba Group.